Tokyo’s Eisai will provide clinical updates regarding its selective TKI Lenvima (lenvatinib), also marketed as Kisplyx, at the forthcoming annual meeting of the 10 October 2018
At the upcoming congress of the European Society for Medical Oncology (ESMO), Eli Lilly will present a range of new data, including on the investigational compo 10 October 2018
Zug, Switzerland-based oncology specialist Tesaro says it will present six abstracts at the upcoming annual meeting of the European Society for Medical Oncology 10 October 2018
A fruitful congress of the European Society of Medical Oncology last week provided key insights into melanoma, lung, kidney and ovarian cancer research. 19 September 2017
Roche stock dropped almost 1.5% yesterday after the cancer giant revealed the Phase III BRIM8 study had missed its primary endpoint of disease-free survival in 12 September 2017
Eli Lilly has presented results at the European Society of Medical Oncology congress in Madrid, which look set to bolster the Indianapolis-based firm’s hopes of 11 September 2017
French drugmaker Ipsen and San Francisco’s Exelixis have presented new data from the CABOSUN trial at the European Society of Medical Oncology congress in Madri 10 September 2017
An oral presentation at this year’s European Society of Medical Oncology congress has provided an insight into the impact of stopping treatment with a checkpoin 9 September 2017
Merck & Co has made two presentations from its KEYNOTE clinical program at the European Society of Medical Oncology congress in Madrid, adding to the growing bo 9 September 2017
Another key presentation at the European Society of Medical Oncology congress offers Anglo-Swedish firm AstraZeneca hope of escaping the pall cast over the comp 9 September 2017
London’s AstraZeneca has presented full results from the Phase III FLAURA trial at the top tier presidential symposium of the European Society of Medical Oncolo 9 September 2017
As competition in immuno-oncology hots up, in New York, a biotech startup called Rgenix has entered the fray with RGX-104, a small molecule currently entering P 8 September 2017
Clovis Oncology will present comprehensive data from its Phase III ARIEL3 study of its leading product Rubraca in ovarian cancer. The presentation will take pla 8 September 2017
Roche will present data from 18 approved and investigational programs at the European Society for Medical Oncology Congress, which kicks off in Madrid next Frid 1 September 2017
Germany’s Merck KGaA has said will be presenting 23 abstracts at next week’s European Society for Medical Oncology Congress, one of the leading cancer conferenc 31 August 2017
At next week’s European Society of Medical Oncology Congress in Madrid, Anglo-Swedish drugmaker AstraZeneca and the company’s biologics arm MedImmune will make 31 August 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.